Table 1. Characteristics of RCTs of tobacco use and HIV infection included in selected Cochrane systematic reviews and ongoing RCTs selected from international clinical trial registries.
| Total | Tobacco use | HIV infection | ||||||||
| All | RCTs | Ongoing RCTs | All | RCTs | Ongoing RCTs | All | RCTs | Ongoing RCTs | ||
| n = 1 086 (%) | n = 740 (%) | n = 346 (%) | n = 668 (%) | n = 556 (%) | n = 112 (%) | n = 418 (%) | n = 184 (%) | n = 234 (%) | ||
| Intervention | ||||||||||
| • PT | 489 (45.0) | 283 (38.2) | 206 (59.5) | 252 (37.7) | 201 (36.2) | 51 (45.5) | 237 (56.7) | 82 (44.6) | 155 (66.2) | |
| • NPT | 597 (55.0) | 457 (61.8) | 140 (40.5) | 416 (62.3) | 355 (63.8) | 61 (54.5) | 181 (43.3) | 102 (55.4) | 79 (33.8) | |
| Number of participating countries | ||||||||||
| • 1 | 1 004 (92.5) | 695 (94.0) | 309 (89.3) | 639 (95.7) | 529 (95.1) | 110 (98.2) | 365 (87.3) | 166 (90.2) | 199 (85.0) | |
| • 1–5 | 38 (3.5) | 15 (2.0) | 23 (6.7) | 8 (1.2) | 6 (1.1) | 2 (1.8) | 30 (7.2) | 9 (4.9) | 21 (9.0) | |
| • 6–10 | 10 (0.9) | 4 (0.5) | 6 (1.7) | 4 (0.6) | 4 (0.7) | 0 | 6 (1.4) | 0 | 6 (2.6) | |
| • >10 | 12 (1.1) | 4 (0.5) | 8 (2.3) | 2 (0.3) | 2 (0.4) | 0 | 10 (2.4) | 2 (1.1) | 8 (3.4) | |
| • Not reported | 22 (2.0) | 22 (3.0) | -- | 15 (2.2) | 15 (2.7) | -- | 7 (1.7) | 7 (3.8) | -- | |
RCTs: randomized controlled trials. PT: pharmacologic intervention. NPT: nonpharmacologic intervention.